Home » Topics » Science » New compound

New compound
RSS

CRD-1600 demonstrates robust immune modulatory properties in vitro and in vivo

May 4, 2022

GTX-0196 shows complete tumor growth suppression in models of AML

May 4, 2022

Bridge Biotherapeutics and Cyrus Therapeutics generate next-generation EGFR degraders

May 2, 2022

BBT-207, a fourth-generation EGFR TKI with activity against most common mutants

May 2, 2022

AC-0027875, a gamma-secretase modulator for the treatment of AD

April 29, 2022

KSHN-001034, a novel prodrug that delivers higher fulvestrant concentrations

April 28, 2022

ARTS-021 shows promising antitumor activity in CCNE1-amplified cancer models

April 27, 2022

ZLD-2218, a novel BRD4 inhibitor for the treatment of kidney fibrosis

April 26, 2022

CJRS-10671 and CJRS-10672, biotherapeutic candidates with promising antitumor efficacy in vivo

April 25, 2022

EGFR-TKI TAS-3351 overcomes T790M and C797S mutations tied to NSCLC treatment resistance

April 25, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...